• Report Adverse Event or Product Quality Complaint
  • US Site
  • Global Site
AstraZeneca Medical Information
  • Therapy Areas
    • All Therapeutic Areas
    • Cardiovascular
    • Immunology
    • Infection
    • Metabolic
    • Oncology
    • Renal
    • Respiratory
    • Rare Disease (Alexion)
  • Medications
  • Resources
    • Congress Library
    • Disease Education
    • Pipeline
    • Clinical Trials
    • Open innovation
    • Access 360
    • Affordability Programs
    • Sample Closet
    • Medical Education Grant
    • Rare Disease (Alexion)
  • Connect
    • Connect with Us
    • Find an MSL
    • Request an MSL
    • Submit an MIR
    • Give Feedback
User
  • Login to My AZmedical
  • Register for My AZmedical

Search Medical Information

Oncology

AstraZeneca is pleased to present healthcare professionals with a variety of oncology resources for your informational purposes.
The educational materials are intended to provide disease-state information that can assist you in forming your own clinical and treatment decisions.

  1. Congress Library
  2. Medications
  3. Disease Education
  4. Continuing Education
  5. Pipeline

June 9-12, 2022

European Hematology Association (EHA) Congress 2022

Explore AstraZeneca Scientific Materials Visit Congress Site

June 3-7, 2022

American Society of Clinical Oncology (ASCO) 2022 Annual Meeting

Explore AstraZeneca Scientific Materials Visit Congress Site

May 3-5, 2022

ESMO Breast Cancer Congress 2022

Explore AstraZeneca Scientific Materials Visit Congress Site

April 8-13, 2022

American Association for Cancer Research (AACR) 2022

Explore AstraZeneca Scientific Materials Visit Congress Site

March 30 - April 2, 2022

European Lung Cancer Congress (ELCC) 2022

Explore AstraZeneca Scientific Materials Visit Congress Site

March 18 - 21, 2022

Society of Gynecologic Oncology (SGO) 2022 Annual Meeting

Explore AstraZeneca Scientific Materials Visit Congress Site

March 16-18, 2022

ESMO Virtual Plenary March 2022

Explore AstraZeneca Scientific Materials Visit Congress Site

February 17-19, 2022

American Society of Clinical Oncology - Genitourinary Cancers Symposium (ASCO GU) 2022

Explore AstraZeneca Scientific Materials Visit Congress Site

January 20-22, 2022

American Society of Clinical Oncology - Gastrointestinal Cancers Symposium (ASCO GI) 2022

Explore AstraZeneca Scientific Materials Visit Congress Site

December 11-14, 2021

American Society of Hematology (ASH) 2021

Explore AstraZeneca Scientific Materials Visit Congress Site

December 7-10, 2021

San Antonio Breast Cancer Symposium (SABCS) 2021

Explore AstraZeneca Scientific Materials Visit Congress Site

November 2-10, 2021

American College of Rheumatology (ACR) Convergence 2021

Explore AstraZeneca Scientific Materials Visit Congress Site

October 23-25, 2021

European Society of Gynaecological Oncology (ESGO) Congress 2021

Explore AstraZeneca Scientific Materials Visit Congress Site

September 16-21, 2021

European Society for Medical Oncology (ESMO) 2021

Explore AstraZeneca Scientific Materials Visit Congress Site

September 8-14, 2021

IASLC 2021 World Congress on Lung Cancer  (WCLC)

Explore AstraZeneca Scientific Materials Visit Congress Site

June 18-22, 2021

International Congress on Malignant Lymphoma (ICML)

Explore AstraZeneca Scientific Materials Visit Virtual Congress Site

June 4-8, 2021

American Society of Clinical Oncology (ASCO) 2021 Annual Meeting

Explore AstraZeneca Scientific Materials Visit Virtual Congress Site

May 5-8, 2021

ESMO Breast Cancer Virtual Congress 2021

Explore AstraZeneca Scientific Materials Visit Virtual Congress Site

April 10 -15, 2021

American Association for Cancer Research (AACR) 2021

Explore AstraZeneca Scientific Materials Visit Virtual Congress Site

March 19 -25, 2021

Society of Gynecologic Oncology 2021

Explore AstraZeneca Scientific Materials Visit Virtual Congress Site

Feb 11-13, 2021

ASCO Genitourinary Cancers Symposium (ASCO-GU) 2021

Explore AstraZeneca Scientific Materials Visit Virtual Congress Site

Jan 28-31, 2021

World Conference on Lung Cancer(WCLC)

Explore AstraZeneca Scientific Materials Visit Virtual Congress Site

Redirecting...

  • CALQUENCE® (acalabrutinib) capsules
  • FASLODEX® (fulvestrant) injection, for intramuscular use
  • IMFINZI® (durvalumab) injection, for intravenous use
  • IRESSA® (gefitinib) Tablets
  • LYNPARZA® (olaparib) Capsules
  • LYNPARZA® (olaparib) Capsules
  • TAGRISSO® (osimertinib) Tablets

VIDEO

VIDEO

HER2 NSCLC Mutation MOD Animation

This video is a series of 3D animated videos on HER2 mutations in NSCLC.


WEBSITE

WEBSITE

AstraZeneca Oncology Pipeline Tool

Explore the AstraZeneca Oncology Pipeline by Tumour Type, Cell Pathway and Scientific Pillars.


e-Learning

Annual Meeting 2022

American Association for Thoracic Surgery

18-May-2022 to 01-Sep-2022

The Annual Meeting of the AATS is the flagship gathering for the Association to disseminate new and developing information about the care of cardiothoracic patients to surgeons and allied health personnel around the world.

Learn More

e-Learning

Webcast-Seattle Multidisciplinary Lung Cancer Conference

Binaytara Foundation

01-Nov-2021 to 31-Oct-2022

This accredited continuing education activity “Seattle Multidisciplinary Lung Cancer Conference”, is recorded from the live conference held on 10/23/2021 at the Crowne Plaza Downtown Seattle.

Learn More

e-Learning

Live Web Annual Meeting 2022

American Association for Thoracic Surgery

18-May-2022 to 01-Sep-2022

The Annual Meeting of the AATS is the flagship gathering for the Association to disseminate new and developing information about the care of cardiothoracic patients to surgeons and allied health personnel around the world.

Learn More

e-Learning

Targeted Therapy for NSCLC: New Frontiers

Haymarket Medical Education

30-Apr-2022 to 30-Apr-2022

An enduring webcast of a live presentation made at the ONA Summit meeting on March 27, 2022.

Learn More

e-Learning

Lightning Reports™ from ASCO 2022: Targeted Therapy in Lung Cancer

Rush University Medical Center

06-Jun-2022 to 31-May-2023

This series of certified enduring videos spotlight the latest advances in the management of lung cancer treated with targeted therapy through a series of ‘what you need to know’ videos featuring a leading expert reporting from the 2022 ASCO Meeting.

 

Learn More

e-Learning

Time for Even More Precision in Testing and Treatment of EGFR-Mutated NSCLC: Refining and Expanding Best Practices in Advanced and Early-Stage Disease Settings

Medical Learning Institute Inc

29-Oct-2021 to 28-Nov-2022

A 1.0 credit hour online enduring activity (PeerView onDemand)

Point-of-care practice tools

 

Learn More

e-Learning

Adjuvant EGFR-Targeted Therapy as a Game Changer: How to Implement New Standards of Care in Multimodal Management of Stage I-III EGFR-Mutated NSCLC

Medical Learning Institute Inc

03-Nov-2021 to 02-Dec-2022

A 1.0 credit hour online enduring activity (PeerView onDemand)

Point-of-care practice tools

Learn More

e-Learning

Bringing Precision Oncology to Early-Stage Lung Cancer, With Adjuvant EGFR-Targeted Therapy Leading the Way: What Thoracic Surgeons Need to Know and Do

Medical Learning Institute Inc

30-Jan-2022 to 27-Feb-2023

A 1.5 credit hour online enduring activity (PeerView onDemand)

Point-of-care practice tools

Learn More

e-Learning

Online Enduring Community Practice Connections™: Medical Crossfire®: Current and Emerging Applications of Liquid Biopsies Across Cancer Care

Physicians’ Education Resource®, LLC (PER)

31-Aug-2021 to 31-Aug-2022

A multi-component “interactive presentation” archived for 1 year

Learn More

e-Learning

Online: Community Practice Connections™ 16th Annual New York Lung Cancers Symposium

Physicians’ Education Resource®, LLC (PER)

31-Jan-2022 to 31-Jan-2023

Series on online activities extending the live meeting

Learn More

e-learning

Medical Crossfire®: Implications of Tumor Testing Results Across Advanced NSCLC Treatment Online Program

Physicians’ Education Resource®, LLC (PER)

23-Dec-2021 to 23-Dec-2022

An Endured online program of the live taping.

Learn More

e-learning

Precision Medicine; Understanding the Commission on Cancer; Technology Innovation Integration to Address Underserved Disparate Patient Populations; Navigation Certification: Overview, Value and Preparation

AKH Inc., Advancing Knowledge in Healthcare

15-Feb-2022 to 14-Feb-2023

Designed to address the questions of navigators, social workers, physicians, and administrators in regard to cancer care, and offer practical solutions from experts and peers in implementing ...

Learn More

e-Learning

Molecular Laboratory Management and Reporting: A Short Course for Laboratory Professionals

Amedco, LLC

 01-Aug-2020 to 31-Dec-2022

Ten (10) hours of enduring webinars on Laboratory  Management

Learn More

e-Learning

Real-World Evidence

Friends of Cancer Research

11-Apr-2022 to 30-Dec-2022

Web/Enduring Activities

Learn More

e-Learning

Circulating Tumor DNA (ctDNA)

Friends of Cancer Research

11-Apr-2022 to 30-Dec-2022

Web/Enduring Activities

Learn More

e-Learning

HRD Harmonization Project

Friends of Cancer Research

11-Apr-2022 to 30-Dec-2022

Web/Enduring Activities

Learn More

e-Learning

Measuring rwResponse in Electronic Health Records

Friends of Cancer Research

11-Apr-2022 to 30-Dec-2022

Virtual Public Meeting

Learn More

e-Learning

Annual Meeting

Friends of Cancer Research

11-Apr-2022 to 30-Dec-2022

Virtual Public Meeting

Learn More

e-Learning

ctDNA Roadmap-Linking Evidence with Regulatory Policy

Friends of Cancer Research

11-Apr-2022 to 30-Dec-2022

Virtual Public Meeting

Learn More

Podcast

Expert Insights on New and Emerging Therapies for Breast Cancer

PRIME Education, LLC

23-Feb-2022 to 31-Dec-2022

1 hour webcast

Learn More

PODCAST

Developments in Molecular Testing and Systemic Therapies for Advanced and Metastatic NSCLC

PRIME Education, LLC

07-Jan-2022 to 31-Dec-2022

1 hour webcast

Learn More

Podcast

Transforming the Management of Pancreatic Cancer: Targeting the DNA Damage Repair Pathways

Imedex, LLC

29-Nov-2021 to 29-Nov-2022

On-demand webcast, based on the GDU GI 2021 Pancreatic Cancer session proceedings.

Learn More

Podcast

Improving Outcomes in Gastric Cancer: Advances in Targeted Treatment Strategies

Imedex, LLC

29-Nov-2021 to 29-Nov-2022

On-demand webcast, based on the GDU GI 2021 Gastric Cancer session proceedings.

Learn More

e-Learning

THE IMPORTANCE OF LUNG CANCER SCREENING

 National Committee for Quality Assurance

29-Jun-2022 to 31-Mar-2023

This program will discuss the expanded USPSTF recommendations, changes in the reimbursement landscape, including the recent change in the Medicare National Coverage Determination..

Learn More

e-Learning

Addressing Key Targets in Advanced NSCLC: Evaluating the Latest Evidence and Clinical Opportunities for HER2-, HER3-, and TROP2-Targeted Therapies

PVI, PeerView Institute for Medical Education

22-Feb-2022 to 21-Mar-2023

A 1.0 credit hour online enduring activity (PeerView onDemand) Point-of-care practice tools

Learn More

e-Learning

Web Enduring Addressing Key Targets in Advanced NSCLC: Evaluating the Latest Evidence and Clinical Opportunities for HER2-, HER3-, and TROP2-Targeted Therapies

PVI, PeerView Institute for Medical Education

22-Feb-2022 to 21-Mar-2023

A 1.0 credit hour online enduring activity (PeerView onDemand) Point-of-care practice tools

Learn More

e-Learning

Online Enduring Top 10 Oncogenic Markers in Advanced NSCLC: What You Need to Know About Testing, Trials, and Novel Therapies

Physicians’ Education Resource®, LLC (PER)

31-Aug-2021 to 31-Aug-2022

A multi-component “interactive presentation” which includes slides and short expert interviews archived for 1 year.

Learn More

e-Learning

Online Enduring 22nd Annual International Lung Cancer Conference

Physicians’ Education Resource®, LLC (PER)

31-Oct-2021 to 31-Oct-2022

An online activity based on the live content

Learn More

e-Learning

Online Enduring Activity: Community Practice Connections™: 3rd Annual Precision Medicine Symposium: An Illustrated Tumor Board

Physicians’ Education Resource®, LLC (PER)

31-Oct-2021 to 31-Oct-2022

An online activity based on the live content

Learn More

e-Learning

Online: Clinical Vignette Series 39th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®

Physicians’ Education Resource®, LLC (PER)

31-Jan-2022 to 31-Jan-2023

Online Clinical Vignette Series

Learn More

e-Learning

Hope Is Here in CLL: Oncology Nurse Strategies for Delivering Effective, Compassionate, and Modern Care to Patients

PVI, PeerView Institute for Medical Education, Inc.

20-May-2022 to 19-May-2023

1.5 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-learning

Recent Advances in the Treatment and Management of Chronic Lymphocytic Leukemia (CLL): Expert Perspectives on the Evolving Role of BTK Inhibitors and Combination Therapy

National Association of Managed Care Physicians, Inc.

01-Apr-2021 to 01-Apr-2023

Three 1-hour enduring webcasts recorded from live webinars

Learn More

e-Learning

Best Practices in the Treatment and Management of Chronic Lymphocytic Leukemia (CLL): An In-Depth Look at BTK Inhibitors and Combination Regimens

National Association of Managed Care Physicians, Inc.

01-Jan-2022 to 01-Mar-2023

CLL

Learn More

Podcast

Novel Bruton Kinase Inhibitors in CLL/SLL: Treatment Selection Strategies for Optimal Patient Outcomes

Imedex, LLC

 23-Nov-2021 to 23-Nov-2022

On-demand Webcast, based on the LL&M 2021 session proceedings.

Learn More

e-Learning

The Utility of Novel Therapies in CLL/SLL Clinical Pathways: Opportunities to Facilitate Treatment Selection and Sequencing

NACCME LLC

29-Oct-2021 to 29-Oct-2022

Enduring on-demand web archive based on the session at OCPC 2021.

Learn More

PODCAST

Audio Identifying, Managing and Mitigating Therapy-Related Adverse Events in Patients with Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma

Research To Practice

04-Nov-2021 to 04-Nov-2022

Audio Proceedings

Learn More

E-LEARNING

Faculty Presentation Identifying, Managing and Mitigating Therapy-Related Adverse Events in Patients with Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma

Research To Practice

04-Nov-2021 to 04-Nov-2022

Faculty Video Presentations

Learn More

E-LEARNING

Live CME Webinar Identifying, Managing and Mitigating Therapy-Related Adverse Events in Patients with Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma: A Live CME Webinar and Related Enduring Activities

Research To Practice

04-Nov-2021 to 04-Nov-2022

Video Proceedings

Learn More

e-Learning

Identifying, Managing and Mitigating Therapy-Related Adverse Events in Patients with Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma

Research To Practice

04-Nov-2021 to 04-Nov-2022

Video Proceedings

Learn More

e-Learning

Customizing Care in CLL With BTK Inhibitors: Evidence and Applications for Therapy Selection, Sequencing, and Safety Management

Medical Learning Institute Inc

10-Dec-2021 to 09-Jan-2023

A 1.5 credit hour online enduring activity (PeerView onDemand)

Point-of-care practice tools

Learn More

e-Learning

Web Enduring Program - Seizing the Day With BTK Inhibitors in CLL: Evidence-Informed Therapy Selection, Safety, and Sequential Care

Medical Learning Institute Inc

09-Sept-2021 to 08-Sept-2022

 A 1.5 hour learner-interactive online enduring activity
 Point-of-care practice tools

Learn More

e-Learning

Achieving Innovation in CLL Care: Evidence-Informed Choices With Targeted Options and Next Steps in Disease Management

The Pennsylvania State University

10-Dec-2021 to 09-Jan-2023

A 2.0 credit hour online enduring activity (PeerView onDemand) and Point-of-care practice tools

Learn More

E-LEARNING

Enduring Personalizing and Advancing Modern Treatment Approaches to Prostate Cancer

Medical Learning Institute Inc

06-May-2022 to 04-May-2023

0.25 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Live Web Making Sense of New Standards for CLL: Pharmacy Insights on Targeted Therapy and Effective Delivery of Team-Based Care

Medical Learning Institute Inc

06-May-2022 to 05-June-2023

0.25 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Rewriting the Treatment Script in CLL: Guidance on Integrating Modern Targeted and Next-Gen Options Into Patient Care

Medical Learning Institute Inc

04-Jun-2022 to 03-Jul-2023

1.50 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Online – Medical Crossfire®: Hematologic Malignancies

Physicians’ Education Resource®, LLC (PER)

31-Aug-2021 to 31-Aug-2022

An online CME-Certified activity endured for 1 year

Learn More

e-Learning

Online Activity - Community Practice Connections™ 26th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma

Physicians’ Education Resource®, LLC (PER)

15-Apr-2022 to 15-Apr-2023

A series of interviews with noted thought leaders

Learn More

Podcast

Expert Insights on New and Emerging Therapies for Breast Cancer

PRIME Education, LLC

23-Feb-2022 to 31-Dec-2022

1 hour webcast

Learn More

e-Learning

Live Web - Addressing Key Targets in Advanced NSCLC: Evaluating the Latest Evidence and Clinical Opportunities for HER2-, HER3-, and TROP2-Targeted Therapies

PVI, PeerView Institute for Medical Education

22-Feb-2022 to 21-Mar-2023

A 1.0 credit hour online enduring activity (PeerView onDemand) Point-of-care practice tools

Learn More

e-Learning

Web Enduring - Addressing Key Targets in Advanced NSCLC: Evaluating the Latest Evidence and Clinical Opportunities for HER2-, HER3-, and TROP2-Targeted Therapies

PVI, PeerView Institute for Medical Education

22-Feb-2022 to 21-Mar-2023

A 1.0 credit hour online enduring activity (PeerView onDemand) Point-of-care practice tools

Learn More

Podcast

Novel Bruton Kinase Inhibitors in CLL/SLL: Treatment Selection Strategies for Optimal Patient Outcomes

Imedex, LLC

 23-Nov-2021 to 23-Nov-2022

On-demand Webcast, based on the LL&M 2021 session proceedings.

Learn More

e-Learning

The Utility of Novel Therapies in CLL/SLL Clinical Pathways: Opportunities to Facilitate Treatment Selection and Sequencing

NACCME LLC

29-Oct-2021 to 29-Oct-2022

Enduring on-demand web archive based on the session at OCPC 2021.

Learn More

e-Learning

Customizing Care in CLL With BTK Inhibitors: Evidence and Applications for Therapy Selection, Sequencing, and Safety Management

Medical Learning Institute Inc

10-Dec-2021 to 09-Jan-2023

A 1.5 credit hour online enduring activity (PeerView onDemand)

Point-of-care practice tools

Learn More

e-Learning

Customizing Care in CLL With BTK Inhibitors: Evidence and Applications for Therapy Selection, Sequencing, and Safety Management

Medical Learning Institute Inc

10-Dec-2021 to 09-Jan-2023

A 1.5 credit hour online enduring activity (PeerView onDemand)

Point-of-care practice tools

Learn More

e-Learning

Web Enduring Program - Seizing the Day With BTK Inhibitors in CLL: Evidence-Informed Therapy Selection, Safety, and Sequential Care

Medical Learning Institute Inc

09-Sept-2021 to 08-Sept-2022

 A 1.5 hour learner-interactive online enduring activity
 Point-of-care practice tools

Learn More

e-Learning

Web Enduring - Making Sense of New Standards for CLL: Pharmacist Insights on Targeted Therapy and the Delivery of Team-Based Care

Medical Learning Institute Inc

06-May-2022 to 04-May-2023

0.25 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Live Web - Making Sense of New Standards for CLL: Pharmacy Insights on Targeted Therapy and Effective Delivery of Team-Based Care

Medical Learning Institute Inc

06-May-2022 to 05-June-2023

0.25 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Rewriting the Treatment Script in CLL: Guidance on Integrating Modern Targeted and Next-Gen Options Into Patient Care

Medical Learning Institute Inc

04-Jun-2022 to 03-Jul-2023

1.50 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

The Utility of Novel Therapies in CLL/SLL Clinical Pathways: Opportunities to Facilitate Treatment Selection and Sequencing

NACCME LLC

29-Oct-2021 to 29-Oct-2022

Enduring on-demand web archive based on the session at OCPC 2021.

Learn More

e-learning

Recent Advances in the Treatment and Management of Chronic Lymphocytic Leukemia (CLL): Expert Perspectives on the Evolving Role of BTK Inhibitors and Combination Therapy

National Association of Managed Care Physicians, Inc.

01-Apr-2021 to 01-Apr-2023

Three 1-hour enduring webcasts recorded from live webinars

Learn More

e-Learning

Evolving Considerations in the Treatment and Management of Chronic Lymphocytic Leukemia (CLL): Expert Strategies on Emerging Combination Therapies

National Association of Managed Care Physicians, Inc.

01-Aug-2021 to 01-Aug-2022

CLL

Learn More

e-Learning

Best Practices in the Treatment and Management of Chronic Lymphocytic Leukemia (CLL): An In-Depth Look at BTK Inhibitors and Combination Regimens

National Association of Managed Care Physicians, Inc.

01-Jan-2022 to 01-Mar-2023

CLL

Learn More

e-Learning

Online – Medical Crossfire®: Hematologic Malignancies

Physicians’ Education Resource®, LLC (PER)

31-Aug-2021 to 31-Aug-2022

An online CME-Certified activity endured for 1 year

Learn More

e-Learning

Online Activity - Community Practice Connections™ 26th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma

Physicians’ Education Resource®, LLC (PER)

15-Apr-2022 to 15-Apr-2023

A series of interviews with noted thought leaders

Learn More

e-Learning

Harmonizing HCC Care With a Multidisciplinary Ensemble: Guidance for the Era of Novel Locoregional, Multimodal, and Systemic Strategies

Medical Learning Institute Inc

14-Nov-2021 to 13-Dec-2022

A 1.5 credit hour online enduring activity (PeerView onDemand)

Point-of-care practice tools

Learn More

e-Learning

Web Enduring Program -Maximizing the Potential of Immunotherapy in Multimodal Management of Unresectable Stage III NSCLC: Collaboration Is Crucial, Patient Selection Is Paramount, Close Monitoring Is Critical

PVI, PeerView Institute for Medical Education, Inc.

06-Sept-2021 to 05-Spet-2022

A 1.0 hour learner-interactive online enduring activity
Point-of-care practice tools

Learn More

e-Learning

Maintaining Vigilance to Mitigate Cancer Immunotherapy-Related Toxicities in the Emergency Department: Be Aware, Stay Alert, and Change Your Practice

Medical Learning Institute Inc

25-Oct-2021 to 24-Nov-2022

A 1.0 credit hour online enduring activity (PeerView onDemand)

Point-of-care practice tools

Learn More

e-Learning

Embracing the Era of Individualized Therapy in Advanced Biliary Cancers: Expert Strategies for Applying New and Emerging Targeted Treatment Options Through Precision Medicine

Medical Learning Institute Inc

22-Jan-2022 to 21-Feb-2023

A 1.5 credit hour online enduring activity (PeerView onDemand)

Point-of-care practice tools

Learn More

e-Learning

Translating Science, Transforming Practice, and Making Headway Toward Better Outcomes in SCLC: Immunotherapy Has Changed the Game, but Where Do We Go Next?

Medical Learning Institute Inc

30-Oct-2021 to 29-Nov-2022

A 1.0 credit hour online enduring activity (PeerView onDemand)

Point-of-care practice tools

Learn More

e-Learning

Mapping the Optimal Treatment Route in HCC: Identifying Best Practices in an Expanding Therapeutic Landscape

Medical Learning Institute Inc

21-Jan-2022 to 20-Feb-2023

A 1.5 credit hour online enduring activity (PeerView onDemand)

Point-of-care practice tools

Learn More

e-Learning

Transforming Bladder Cancer Treatment: Essential Guidance for Urologists on Therapeutic Selection, Safety, and Sequencing Along the Disease Continuum

The Pennsylvania State University

30-June-2022 to 29-June-2023

1.0 credit hour on-demand self-study enduring activity

Learn More

e-Learning

Achieving State-of-the-Art Care in Bladder Cancer in an Era of Innovative Therapeutic Solutions

Medical Learning Institute Inc

18-Feb-2022 to 17-Mar-2023

A 1.50 credit hour online enduring activity (PeerView onDemand) and point-of-care practice tools

Learn More

e-learning

Making Headway Towards Better Outcomes in Intermediate-to-Advanced-Stage HCC: A Multidisciplinary Tumor Board on Implementing Novel Locoregional and Systemic Approaches in the Interventional Radiology Setting

Medical Learning Institute Inc

08-Jul-2022 to 07-Jul-2023

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-learning

Urology Clinical Consults: Bladder Cancer Cases from the Community: Expert Guidance on Translating the Latest Therapeutic Advances Into Patient Care for Early to Advanced Bladder Cancer

Medical Learning Institute Inc

15-May-2022 to 14-Jun-2023

A 1.5 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Setting the Course for the Optimal Management of HCC: Improving Patient Outcomes Through the Integration of Novel Therapeutic Approaches Across the Continuum of Care

PVI, PeerView Institute for Medical Education, Inc.

05-Jun-2022 to 04-Jul-2023

1.5 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Blazing the Trail Forward in the Therapeutic Management of Bladder Cancer: Expert Insights on Incorporating the Latest Evidence and Treatment Advancements Into Practice Across the Disease Continuum

PVI, PeerView Institute for Medical Education

06-Jun-2022 to 05-Jul-2023

1.50 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Online: Community Practice Connections™ 18th Annual Meeting of the International Society of Gastrointestinal Oncology

Physicians’ Education Resource®, LLC (PER)

30-Nov-2021 to 30-Nov-2022

a 2-day, multidisciplinary hybrid educational conference dedicated to presenting and discussing the latest advances in the broad field of gastrointestinal (GI) cancer research

Learn More

Podcast

Global Advancements in Prostate Cancer: The Role of Genetic Testing & PARP Inhibitors

AUAU Activity
Webcast

American Urological Association Education and Research, Inc.

13-Apr-2022 to 23-Jul-2023

four interactive, case-based, live virtual courses conducted in English, Mandarin, Portuguese, and Spanish. For each session, a Moderator will engage two other subject matter experts in an interactive, interview-style presentation and discussion.

Learn More

Podcast

Global Advancements in Prostate Cancer: Best Practices in Hormonal Therapy

AUAU Activity
Webcast

American Urological Association Education and Research, Inc.

13-Apr-2022 to 13-Apr-2023

Educational initiative featuring a Moderator and two other subject matter experts in an interactive, interview-style presentation and discussion.

Learn More

e-Learning

(Great Debates and Updates in Women's Oncology 2022) HER2-positive Breast Cancer: Treatment Strategies with New and Emerging Therapies

NACCME LLC

21-Sept-2022 to 23-Sept-2022

30- to 45-minute session on HER2-positive breast cancer to be presented at both of the Great Debates & Updates in Women's Oncology events. Led by expert faculty members distinguished within the field of HER2-positive breast cancer.

Learn More

E-LEARNING

TumorBoard Tues (TBT) – Cases in Breast Cancer

Integrity Continuing Education, Inc.

18-May-2022 to 17-May-2023

Twitter-based tumor board and clinician community with regularly scheduled discussions conducted via Twitter. The breast cancer portion of the series includes 12 tumor boards focused on the topic of breast cancer.

Learn More

PODCAST

Advanced Ovarian Cancer: New Insights on Making the Most of Mutations and Biomarkers to Inform Treatment Plans

CME Outfitters, LLC

03-Mar-2022 to 03-Mar-2023

OnDemand Webcast

Learn More

E-LEARNING

Recent Advances in the Treatment and Management of Ovarian Cancer: Expert Perspectives on the Evolving Role of PARP Inhibitors

National Association of Managed Care Physicians, Inc.

01-Jan-2022 to 01-Mar-2023

Ovarian Cancer

Learn More

E-LEARNING

Adapting to Evolving Treatment Paradigms in Prostate Cancer: New Evidence and Opportunities

National Association of Managed Care Physicians, Inc.

01-Jan-2022 to 01-Mar-2023

Prostate

Learn More

E-LEARNING

Evolving Considerations in the Treatment and Management of Metastatic Breast Cancer: Expert Strategies for Improved Clinical and Economic Outcomes

National Association of Managed Care Physicians, Inc.

01-Jan-2022 to 01-Mar-2023

mBC

Learn More

E-LEARNING

Navigating an Increasingly Complex Treatment Paradigm in the Management of HER2-Positive Advanced Breast Cancer: An In-Depth Look at New and Emerging Therapies

National Association of Managed Care Physicians, Inc.

01-Jan-2022 to 01-Mar-2023

HER2 BC

Learn More

e-Learning

2021 AUA Expert Exchange Podcast: Discussions in GU Cancer

 American Urological Association Education and Research, Inc.

20-Oct-2021 to 20-Oct-2022

Advances in Immuno-Oncology in Urothelial Carcinoma has been released on 10/20.

Learn More

e-Learning

Virtual Tumor Board 2: HER2 Testing in Breast Cancer: Improving IHC Performance

American Society for Clinical Pathology

17-Feb-2022 to 31-Oct-2022

1 hour CME/CMLE credit bearing recorded virtual tumor board

Learn More

e-Learning

Podcast 1: The Science of HER2-low Breast Cancer and Implications for the Pathology Team

American Society for Clinical Pathology

03-Mar-2022 to 31-Oct-2022

1 hour CME/CMLE credit bearing recorded virtual tumor board

Learn More

e-Learning

HER2-low Breast Cancer Pathology Implementation Guide

American Society for Clinical Pathology

29-Jul-2022 to 31-Oct-2022

A CME/CMLE credit-bearing downloadable pathology implementation guide (PDF)

Learn More

e-Learning

Podcast #2: HER2 Testing in Breast Cancer: Improving IHC Performance

American Society for Clinical Pathology

03-Mar-2022 to 31-Oct-2022

1 hour CME/CMLE credit bearing recorded virtual tumor board

Learn More

e-Learning

Virtual Tumor Board 1: The Science of HER2-low Breast Cancer and Implications for the Pathology Team

American Society for Clinical Pathology

03-Feb-2022 to 31-Oct-2022

1 hour CME/CMLE credit bearing recorded virtual tumor board

Learn More

e-Learning

HER2-low Breast Cancer Slideset

American Society for Clinical Pathology

03-Mar-2022 to 31-Oct-2022

A short, non-credit‒bearing downloadable slideset

Learn More

E-LEARNING

Trailblazers Meeting #1

American Society for Clinical Pathology

01-Sept-2022 to 01-Oct-2022

1-hr live discussion

Learn More

E-LEARNING

Trailblazers Meeting #2

American Society for Clinical Pathology

01-Oct-2022 to 11-Oct-2022

1-hr live discussion

Learn More

E-LEARNING

ASCP Annual Meeting Session

American Society for Clinical Pathology

08-Sept-2022 to 08-Sept-2022

1-hr live educational session

Learn More

E-LEARNING

HER2-Positive Metastatic Breast Cancer: New Options, New Hope

Haymarket Medical Education

30-Apr-2022 to 30-Apr-2023

Capture from the live 2022 Oncology Nurse Advisor Summit meeting held virtually on March 25th, 2022

Learn More

E-LEARNING

Live Web Personalizing and Advancing Modern Treatment Approaches to Prostate Cancer

Medical Learning Institute Inc

01-Dec-2021 to 31-Dec-2022

 A 1.0 credit hour online enduring activity (PeerView onDemand)
 Point-of-care practice tools

Learn More

E-LEARNING

Enduring Personalizing and Advancing Modern Treatment Approaches to Prostate Cancer

Medical Learning Institute Inc

06-May-2022 to 04-May-2023

0.25 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

When Are PARP Inhibitors the Best Choice for Patients With Ovarian Cancer? Personalizing Therapeutic Selection Across the Disease Continuum

Medical Learning Institute Inc

22-Mar-2022 to 21-Apr-2023

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

E-LEARNING

Expanding the Benefits of PARP Inhibitor Therapy to More Patients With Breast Cancer and Earlier Disease Settings

Medical Learning Institute Inc

08-Apr-2022 to 07-May-2023

A 1.25 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

E-LEARNING

Making Sense of the Evolving Treatment Landscape in Ovarian Cancer Care: Pharmacy Perspectives on PARP Inhibitor Therapy

Medical Learning Institute Inc

13-Apr-2022 to 12-May-2023

A 1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Tackling the Practicalities of Antibody–Drug Conjugate Therapy for Solid Tumors: Improving Clinical Care With HER2-, HER3-, and TROP2-Targeted Therapies

PVI, PeerView Institute for Medical Education, Inc.

19-May-2022 to 18-May-2023

1.5 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Decoding the Latest Evidence and Practical Recommendations on Biomarker Testing for New Therapeutic Options Targeting HER2, HER3, and TROP2 in Solid Tumors

Medical Learning Institute Inc

23-Mar-2022 to 22-Apr-2023

A 1.5 hour video learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Translating Progress With Immunotherapies and Targeted Agents Into Improved Outcomes in Triple-Negative Breast Cancer

PVI, PeerView Institute for Medical Education

12-Mar-2022 to 11-Apr-2023

A 1.0 credit hour online enduring activity (PeerView onDemand) and Point-of-care practice tools

Learn More

e-Learning

Harnessing the Potential of PARP Inhibitors in mCRPC: Reporting on First-line Combination Strategies

Answers in CME Inc.

15-Sept-2021 to 14-Sept-2022

ME Bulletin is a text-based content, interspersed with key graphics. The content will be presented in a series of 5 sessions and delivered to the target audience across multiple digital platforms.

Learn More

e-Learning

HER2-low Testing in Breast Cancer: Emerging Treatment Options Require A New Approach to Testing – ClinicalThought™ Commentary

American Society for Clinical Pathology

04-Mar-2022 to 31-Oct-2022

A non-credit‒bearing email commentary sent to oncologists

Learn More

e-Learning

Online Enduring 20th Annual International Congress on the Future of Breast Cancer

Physicians’ Education Resource®, LLC (PER)

30-Sept-2021 to 30-Sept-2022

A series of interviews based on the live

Learn More

e-Learning

Online: Community Practice Connections™ 19th Annual School of Breast Oncology

Physicians’ Education Resource®, LLC (PER)

31-Jan-2022 to 31-Jan-2023

Series of interactive lectures that follow the live meeting

Learn More

e-Learning

Coffee Talk: Aligning the Data with Strategy to Improve Breast Cancer Outcomes with PARP, HER2/3, and TROP2 Targeted Regimens

Physicians’ Education Resource®, LLC (PER)

30-Apr-2022 to 30-Apr-2023

Online program (Community Practice Connections)

Learn More

e-Learning

Archived Symposium: 2022 MBCC NGS Workshop™: Breast Cancer Edition

Physicians’ Education Resource®, LLC (PER)

15-Apr-2022 to 15-Apr-2023

Enduring Archived Symposium

Learn More

E-LEARNING

PER® 2022 MBCC Hybrid ISS: Integrating New Treatment Options into the Management of Triple Negative Breast Cancer: An Expert Tumor Board Discussion

Physicians’ Education Resource®, LLC (PER)

30-May-2022 to 30-May-2023

text-and-video-based online activity

Learn More

E-LEARNING

7th Annual School of Gastrointestinal Oncology®

Physicians’ Education Resource®, LLC (PER)

31-May-2022 to 31-May-2023

Community Practice Connections online activity

Learn More

Redirecting...

Welcome to AstraZeneca
Medical Information

The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries.

This web site is intended to help healthcare professionals practicing in the US and AstraZeneca authorized persons find scientifically balanced, evidence-based information about AstraZeneca drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.

Are you a healthcare professional practicing in the United States?

I am an AstraZeneca authorized person   What is an AstraZeneca authorized person?This website is only intended for healthcare professionals practicing in the United States and authorized AstraZeneca personnel. AstraZeneca US Headquarters personnel and US Field Medical personnel are authorized to browse and search the database for their own background knowledge and insight. US Field Sales personnel should not access or browse this site. None of the content of this site should be directly linked or distributed without approval.
I am a payer or formulary decision-maker
I am neither (take me to AstraZeneca.com)
AstraZeneca Logo
Pharma Logo

This site is intended for healthcare professionals practicing in the US.

©2022 AstraZeneca. All rights reserved.

US-69609

Last Updated 11/22

Contact Us

About Us

AstraZeneca-US.com

Grant Opportunities

Survey Feedback

Your Privacy Choices

Privacy Notice

Legal Notice

Cookie Notice

US Site

Global Site

Report Adverse Event or Product Quality Complaint

Pharma Logo

Privacy NoticeLegal NoticeCookie Notice